The use of sonophoresis in the administration of drugs throughout the skin

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 12, Issue 1, 2009, Pages 88-115

  Escobar Chávez, José Juan ^a   Bonilla Martínez, Dalia ^a   Villegas González, Martha Angélica ^a   Rodríguez Cruz, Isabel Marlen ^a   Domínguez Delgado, Clara Luisa ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CAFFEINE; CALCIUM ION; CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; DICLOFENAC; DIGOXIN; FENTANYL; FLUFENAMIC ACID; FLUOROURACIL; HYALURONIC ACID; HYDROCORTISONE; HYDROCORTISONE ACETATE; IBUPROFEN; INDOMETACIN; INSULIN; KETOROLAC TROMETAMOL; LIDOCAINE; NICOTINIC ACID METHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; OLIGONUCLEOTIDE; PANAX NOTOGINSENG EXTRACT; PIROXICAM; PLACEBO; UNINDEXED DRUG; DRUG;

ANTIINFLAMMATORY ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG PENETRATION; DRUG RELEASE; DRUG TRANSPORT; GLYCEMIC CONTROL; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYPERGLYCEMIA; INFLAMMATION; KNEE OSTEOARTHRITIS; NONHUMAN; OSTEOARTHRITIS; REVIEW; SKIN ABSORPTION; SKIN DEFECT; SKIN PENETRATION; SKIN PERMEABILITY; SKIN STRUCTURE; SOLID TUMOR; SONOPHORESIS; THERMAL EXPOSURE; THERMODYNAMICS; ULTRASOUND; ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; ECHOGRAPHY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PERMEABILITY; PHYSIOLOGY; SKIN; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, CUTANEOUS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN ABSORPTION; STRUCTURE-ACTIVITY RELATIONSHIP; ULTRASONOGRAPHY;

EID: 70349336849     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3c30d     Document Type: Review

References (90)

1. Wood, R.W., Loomis, A.L. The physical and biological effects of high frequency sound waves of great intensity. Phil. Mag. 4: 417-436, 1927
2. Benwell AD, Bly S.H.P. Sources and applications of ultrasound. In: Repacholi MH, Grandolfo M, Rindi A, editors. Ultrasound: Medical application, biological effects and hazard potentials. New York: Plenum Press. pp. 29-47, 1987.
3. Skauen DM, Zentner GM. Phonophoresis. Int J Pharm 20:235-245,1984.
4. McElnay JC, Matthews MP, Harland R, McCafferty DF. 1985. The effect of ultrasound on the percutaneous absorption of lignocaine. Br J Clin Pharmacol 20:421-424, 1985.
5. Mitragotri S, Blanckschtein D, Langer R. Transdermal drug delivery using low frequency sonophoresis. Pharm Res 13:411-420, 1996.
6. Kost J, Mitragotri S, Gabbay RA, Pishko M, Langer R. Transdermal monitoring of glucose and other analytes using ultrasound. Nature Med 6:327-350, 2000.
7. Amit Joshi, Jaideep Raje. Sonicated transdermal drug transport. J. Control. Rel., 83:13-22, 2002.
8. Kushner IV, J., Blankschtein D., Langer R. Heterogeneity in skin treated with lowfrequency ultrasound. J. Pharm. Sci., 97:4119-4128, 2008.
9. ter Haar G. Therapeutic applications of ultrasound. Progress in Biophysics and Molecular Biology.93:111-129, 2007.
10. Lavon I., Kost J. Ultrasound and transdermal drug delivery. D.D.T., 9(15): 670-676, 2004.
11. Machet L., Boucaud B. Phonophoresis: efficiency, mechanisms and skin tolerance. Int. J. Pharm., 243:1-15, 2002.
12. Merino G., Kalia Y.N., Guy R.H. Ultrasound-Enhanced Transdermal Transport. J. Pharm. Sci., 92:1125-1137, 2003.
13. Forslind B.A. Domain mosaic model of skin barrier. Acta Derm Venereol. 74:1-6, (1994)
14. Potts R.O., Francoeur M.L. The influence of stratum corneum morphology on water permeability. J Invest Dermatol. 96, 495-499, 1991.
15. Potts RO, Guy RH. Predicting skin permeability. Pharm. Res, 9(5): 663-669, 1992.
16. Ellias P.M. Epidermal barrier function: intercellular lamellar lipid structures, origin, composition and metabolism, J Control Rel. 15, 199-208, 1991.
17. Barry B.W. Dermatological Formulations: Percutaneous Absorption. In: Swarbick J, ed. Drugs and the Pharmaceutical Sciences. New York and Basel: Marcel Dekker, Inc. p.202, 1983.
18. Hadgraft J. Skin, the final frontier. Int J Pharm. 224 (1-2):1-18, 2001.
19. Guy R. H and Hadgraft J. Transdermal drug delivery. New York: Marcel Dekker, Inc., p. 1-23, 2003.
20. Walters K. A and Roberts M.S. Dermatological and transdermal formulations. New York: Marcel Dekker, Inc., p. 1-39, 2002.
21. Nevill A.M. The need to scale for differences in body size and mass: and explanation of Kliebeŕs 0.75 mass exponent. Am Physiol Soc. 2870-2873, 1994.
22. Olvera-Martínez B. I, Cazares-Delgadillo J., Calderilla-Fajardo S.B., Villalobos-García R., Ganem-Quintanar A., Quintanar-Guerrero D. Preparation of polymeric nanocapsules containing octyl methoxycinnamate by the emulsification-diffusion technique: Penetration across the stratum corneum. J Pharm Sci. 94:1552-1559, 2005.
23. Escobar-Chávez J.J., Quintanar-Guerrero D., and Ganem-Quintanar A. In vivo skin permeation of sodium naproxen formulated in PF-127 gels: Effect of Azone® and Transcutol®, Drug Develop Ind Pharm. 31:447-454, 2005.
24. Escobar-Chávez J.J., López-Cervantes M., Naïk A., Kalia Y.N., Quintanar-Guerrero D., Ganem-Quintanar A. Applications of the thermoreversible Pluronic F-127 gels in pharmaceutical formulations, J Pharm Pharmaceut Sci. 9(3):339-358, 2006.
25. Miyazaki S, Yokouchi Ch, Nakamura T, Hashiguchi N, Hou W-M, and Takada M. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin, Chem Pharm Bull.34, 1801-1808, 1986.
26. Chi SCh, Do K, Tan HK, and Chun HW. Antiinflammatory and analgesic transdermal gel, United States Patents., Patent number 5,527,832, 1996.
27. Fang JY, Leu YL, Wang YY, and Tsai YH. In vitro topical application and in vivo pharmacodynamic evaluation of nonivamide hydrogels using Wistar rat as an animal model, Eur. J Pharm Sci. 15(5):417-423, 2002.
28. Shin SC, Cho CW, and Oh IJ. Effects of non ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins, Int J Pharm. 222(2), 199-203, 2001.
29. Liaw J, and Lin Y-Ch. Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl, J Control. Rel. 68:273-282, 2000.
30. Wang YY, Hong CT, Chiu WT, and Fang JY. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels, Int J Pharm. 224,1-2, 2001.
31. Kattan El, A. F., Asbill, C. S., Kim, N., and Michniak, B. B. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations, Drug Deliv. 7,3, 2000.
32. Curdy C, Kalia YN, Naïk A, Guy RH. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. J Control Rel. 76, 73-79, 2001.
33. Mattorano DA, Kupper LL, Nylander-French LA. Estimating dermal exposure to jet fuel (naphthalene) using adhesive tape strip samples. Ann Occup Hyg. 48(2): 139-146, 2004.
34. Chao Y-Ch, Nylander-French LA. Determination of Keratin Protein in a Tapestripped Skin Sample from Jet Fuel Exposed Skin. Ann Occup Hyg. 48(1):65-73, 2004.
35. Zagzebski JA. Physics of diagnostic ultrasound. In: Lading DE, Potts L, editors. Essentials of ultrasound physics. St. Louis, MO: Mosby-Year Book, pp. 1-19, 1996.
36. Weyman AE. Physical principles of ultrasound. In: Weyman AE, editor. Principles and practice of echocardiography. Philadelphia: Lea and Febiger, pp.3-28, 1994.
37. Clarke, L., Edwards, A., Graham, E. Acoustic streaming: an in vitro study. Ultrasound Med. Biol. 30, 559-562, 2004.
38. K. Tachibana, S. Tachibana, Application of ultrasound energy as a new drug delivery system, Jpn. J. Appl. Phys. 38(1):3014-3019, 1999.
39. S. Mitragotri, D.A. Edwards, D. Blankschtein, R. Langer, A. Mechanistic study of ultrasonically-enhanced transdermal drug delivery, J. Pharm. Sci. 84(6):697-706, 1995.
40. T.J. Mason, J.P. Lorrimer, Sonochemistry-Theory, applications and uses of ultrasound in chemistry, Ellis Horwood, 1988.
41. T.J. Mason, Practical Sonochemistry: User's Guide To Professor Application in Chemistry and Chemical Engineering, Ellis Horwood, 1991.
42. Mitragotri, S., Kost J. Low-frequency sonophoresis: a noninvasive method of drug delivery and diagnostics, Biotechnol. Prog. 16:488-492, 2000.
43. Tezel A., Sens A., Mitragotri S. Investigation of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy, J. Pharm. Sci. 91(2):444-453, 1998.
44. Tang H., Mitragotri S., Blankschtein D., Langer R. Theoretical description of transdermal transport of hydrophilic permeants: application to low frequency sonophoresis, J. Pharm. Sci., 90(5):543-566, 2001.
45. Lubbers, J., Hekkenberg, R. T, Bezemer, R.A. Time to threshold (TT), a safety parameter for heating by diagnostic ultrasound. Ultrasound Med. Biol. 29, 755-764, 2003.
46. Wells, P.N.T. Physics of ultrasound. In Ultrasonic Exposimetry (Ziskin, M. and Lewin, P., eds), p. 35, CRC Press., 1993.
47. Lavon I., Grossman N., Kost J., Kimmel E., Enden G. Bubble growth within the skin by rectified diffusion might play a significant role in sonophoresis. J. Control. Rel., 117:246-255, 2007.
48. Lavon I., Grossman N., Kost J. The nature of ultrasound-SLS synergism during enhanced transdermal transport. J. Control. Rel., 107:484-494, 2005.
49. Nanda A, Nanda S, Ghilzai N.M. Current developments using emerging transdermal technologies in physical enhancement methods. Curr. Drug Deliv., 3(3):233-242, 2006.
50. Daniel G., Kassan, M.D., Agnes M., Lynch, B.S., Matthew J., Stiller, M.D. Physical enhancement of dermatologic drug: Iontophoresis and phonophoresis delivery: J. Am. Academ. Dermatol.,34(4):657-666, (1996).
51. Maloney M, Bezzant JL, Stephen RL. Iontophoreric administration of lidocaine anesthesia in office practice. J Dermatol Surg Oncol., 18:937-940, 1992.
52. Meshali M.M., Abdel-Aleem H.M., Sakr F.M., Nazzal S., El-Malah Y. In vitro phonophoresis: effect of ultrasound intensity and mode at high frequency on NSAIDs transport across cellulose and rabbit skin membranes, Pharmazie, 63(1):49-53, 2008.
53. Miyazaki S, Mizuoka H, Kohata Y, Takada M. External control of drug release and penetration. Enhancing effect of ultrasound on the transdermal absorption of indomethacin from an oinment in rats, Chem. Pharm. Bull (Tokyo), 40(10):2826-2830, 1992.
54. Tiwari S.B., Pai R.M., Udupa N. Influence of ultrasound on the percutaneous absorption of ketorolac tromethamine in vitro across rat skin, Drug Deliv., 11(1):47-51, 2004.
55. Yang JH, Kim TY, Lee JH, Yoon SW, Yang KH, Shin SC. Anti-hyperalgesic and antiinflammatory effects of ketorolac tromethamine gel using pulsed ultrasound in inflamed rats. Arch. Pharm. Res., 31(4):511-517, 2008.
56. Serikov NP. Efficacy of ibuprofen (nurofen gel) ultraphonophoresis for pain in ostheoarthritis. Ter. Arkh., 79(5):79-81, 2007.
57. Cabak A, Maczewska M, Lyp M, Dobosz J, Gasiorowska U. The effectiveness of phonophoresis with ketoprofen in the treatment of epocondylopathy. Ortop. Traumatol. Rehabil., 37(6):660-665, 2005.
58. Rosim GC, Barbieri CH, Lanças FM, Mazzer N. diclofenac phonphoresis in human volunteers. Ultrasound Med. Biol., 31(3):337-343, 2005.
59. Hippius M., Uhlemann C., Smolenski U., Schreiber U., Reissig S., Hoffmann A. In vitro investigations of drug release and penetration enhancing effect of ultrasound on transmembrane transport of flufenamic acid, Int. Clin. Pharmacol. Ther., 36(2):107-111, 1998.
60. Tachibana K, Tachibana S. Use of ultrasound to enhance the local anesthetic effect of topically applied aqueous lidocaine, Anesthesiology, 78(6):1091-1096, 1993.
61. Hehn B, Moll F. Phonophoretic permeation of procaine hydrochloride through and MDCK cell monolayer. Pharmazie, 51:341-345, 1996.
62. Kim TY, Jung DI, Kim YI, Yang JH, Shin SC. Anesthetic effects of lidocaine hydrochloride gel using low frequency ultrasound of 0.5MHz. J. Pharm. Pharm. Sci., 10(1):1-8, 2007.
63. Liu H., Li S., Pan W., Wang Y., Han F., Yao H Investigation into the potential of low-frequency ultrasound facilitated topical delivery of Cyclosporin A. Int. J. Pharm., 326:32-38, 2006.
64. Pietro SantoiannI, Massimiliano Nino, and Gabriella Calabro. Intradermal drug delivery by low frequency sonophoresis (25KHz). Dermatology on line Journal., 10(2):24-29.
65. Ragelis Siu. Tetracycline penetration into tissue by modified electro and phonophoretic methods, Antibiotiki, 26(9): 699-703, 1981.
66. Aoi A, Watanabe Y, Mori S, Takahashi M, Vassaux G, Kodama T. herpes simplex virus thymidine kinase mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med. Biol., 34(39):425-434, 2007.
67. Meidan VM, Walmsley AD, Docker MF, Irwin WJ. Ultrasound enhanced diffusion into coupling gel during phonophoresis of 5-fluorouracil. 185(2): 205-213, 1999.
68. Luis J, Park EJ, Meyer RJ, Smith NB. Rectangular cymbal arrays for improved ultrasonic transdermal insulin delivery. J. Acoust. Soc. Am., 122(4):2022-2030, 2007.
69. Lee S, Snyder B, Newnham RE, Smith NB. Noninvasive ultrasonic transdermal insulin delivery in rabbits using the light weight cymbal array. Diabetes Techno. Ther., 6(6): 808-815, 2004.
70. Smith N.B., Lee S., Shung K.K. Ultrasoundmediated transdermal in vivo transport of insulin with low profile cymbal arrays. Ultrasound med. Boil., 29(8):1205-1210, 2003.
71. Saliba S., Mistry D.J., Perrin D.H., Gieck J., Weltman A. Phonophoresis and the absorption of dexamethasone in the presence of an occlusive dressing. Journal of Athletic Training, 42(3):349-354, 2007.
72. Byl N.N., McKenzie A., Halliday B., Wong T., O'Connell J The effects of phonophoresis with corticosteroids a controlled pilot study, J. Orthop. Sports Phys. Ther., 18(5):590-600, 1993.
73. Akinbo S.R., Aiyejusunle C.B., Akinyemi O.A., Adesegun S.A., Danesi M.A. Comparison of the therapeutic efficacy of phonophoresis and iontophoresis using dexamethasone sodium phosphate in the management of patients with knee ostheoarthritis. Niger. Postgrad. Med, J., 14(3):190-194, 2007.
74. Yang J.H., Kim D.K., Yun M.Y., Kim T.Y., Shin S.C. Transdermal delivery system of triamcinolone acetonide from a gel using phonophoresis. Arch. Pharm. Res., 29(5):412-427, 2006.
75. Meidan V.M., Docker M.F., Walmsley A.D., Irwin W.J. Phonophoresis of hydrocortisone with enhancers: an acoustically defined model. Int. J. Pharm., 170:157-168,1998.
76. Machet L., Pinton J., Patat F., Arbeille B., Pourcelot L., Vaillant L. In vitro phonophoresis of digoxin across hairless mice and human skin: thermal effect of ultrasoundInternational Journal of Pharmaceutics 133 39-45, 1996.
77. McElnay J.C., Benson H.A., Harland R., Hadgraft J. Phonophoresis of methyl nicotinate. A preliminary study to elucidate the mechanism of action, Pharm. Res., 10(12):1726-1731, 1993.
78. El-Kamel A.H., Al-Fagih I.M., Alsarra I.A. Effect of sonophoresis and chemical enhancers on testosterone transdermal delivery from solid lipid microparticles:an in vitro study, Curr. Drug Deliv., 5(1):20-26, 2008.
79. Park S.R., Jang K.W., Park S-H., Cho H-S., Jin Ch-Z., Choi M.J., Chung S.I., Min B.H. The effect of sonication on simulated osteoarthritis part I: effect of 1 MHz ultrasound on uptake of hyaluronan into the rabbit synovium. Ultrasound Med. Biol., 31(11):1551-1558, 2005
80. Morimoto Y., Mutoh T.M., Ueda H., Fang L., Hirayama K., Atobe M., Kobayashi D. Elucidation of the transport pathway in hairless rat skin enhanced by low-frequency sonophoresis based on the solute-water transport relationship and confocal microscopy. J. Control Rel., 103:587-597, 2005.
81. Tezel H., Dokka S., Kelly S., Hardee G. E., Mitragotri S. Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis. Pharm. Res., 21(12):2219-2225, 2004.
82. Boucaud A., Machet L., Arbeille B., Machet M.C., Sournac M., Mavon, A., Patat F., Vaillant L. In vitro study of low-frequency ultrasoundenhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin. Int. J. Pharm., 228, 69-77, 2001.
83. Menon G.K., Price L. F., Bommannan B., Elias P.M., Feingold K. R. Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion.J. Invest. Dermatol., 102(5):789-795,1994.
84. Ng G.Y., Wong R.Y. Ultrasound phonophoresis of panax notoginseng improves the strength of repairing ligament: a rat model. Ultrasound Med. Biol., 34(12):1919-1923, 2008.
85. Kushner J. IV., Blankschtein D., Langer R. Experimental demonstration of the existence of highly permeable localized transport regions in low-frequency sonophoresis. J. Pharm. Sci., 93:2733-2745, 2004.
86. Alvarez-Román R., Merino G., Kalia Y.N., Naik A., Guy R.H. Skin permeability enhancement by low frequency sonophoresis: Lipid extraction and transport pathways. J. Pharm. Sci., 92, 1138-1146, 2003.
87. Cancel L.M., Tarbell J.M., Ben-Jebria A. Fluorescein permeability and electrical resistance of human skin during low frequency ultrasound application. J Pharm Pharmacol., 56:1109-1118, 2004.
88. Paliwal S., Menon G.K., Mitragotri S. Lowfrequency sonophoresis: ultrastructural basis for stratum corneum permeability assessed using quantum dots. J. Invest. Dermatol., 126, 1095-1101, 2006.
89. Larkin JO, Casey GD, Tangney M, Cashman J, Collins CG, Soden DM, O'Sullivan GC. Effective tumor treatment using optimized ultrasound mediated delivery of bleomycin. Ultrasound Med. Biol., 34(3): 406-413, 2008.
90. Khaibullina A, Jang BS, Sun H, Le N, Yu S, Frenkel V, Carrasquillo JA, Pastan I, Li K. C, Paik CH. Pulsed high intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice. J. Nucl. Med., 49(2):295-302, 2008.